Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Ferrari to pilot 'Back on Track' employee screening for coronavirus

Published 04/08/2020, 04:41 PM
Updated 04/08/2020, 04:45 PM
© Reuters. The logo of Ferrari is seen on a car during the Prague Autoshow in Prague

MILAN (Reuters) - Ferrari (MI:RACE) said on Wednesday it was piloting a project to conduct voluntary screening of employees and their families for coronavirus once the supercarmaker's factories in Italy reopen.

In a statement, Ferrari said its "Back on Track" plan, developed with a pool of virologists and experts, was designed to create a safe working environment for when its operations restarted.

In March the luxury carmaker closed its factories in Maranello and Modena, in the northern Italian region of Emilia-Romagna, in a response to the coronavirus outbreak and a shortage of parts.

It has said it would reopen on April 14, provided it had supplies.

Italy, one of the countries hardest hit by the pandemic, has seen an improvement in infection trends recently and authorities are starting to look ahead to a second phase when lockdown restrictions might be eased.

The lockdown is taking a heavy toll on the already fragile economy, with forecasts of a 6% annual contraction in domestic output deemed "realistic" by the Treasury.

But any reopening of industry is expected to be gradual and subject to a series of conditions being put in place to protect staff from the risk of infection.

As part of the Back on Track plan Ferrari, controlled by the Agnelli family's holding group Exor (MI:EXOR), said it would offer its workers blood tests, on a voluntary basis, to screen for COVID-19.

The tests will also be offered to cohabiting family members and to the staff of suppliers working at the company, it said.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In a final step, each worker will also be given the opportunity to use an App to receive medical support in monitoring the symptoms of the novel coronavirus.

Ferrari said the App would also be used to track the contacts of those involved in the initiative to enhance health monitoring.

In a letter to Exor shareholders, Exor head John Elkann, who is also Ferrari chairman, said the App, while respecting privacy rules, would help monitor and contain the emergence of any new infections amongst employees.

Ferrari's project is backed by Emilia Romagna and the carmaker said it would be sharing results of its project with the region's authorities.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.